James C Chou

9PUBLICATIONS
11CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular medicineInnate immunityGlycoconjugatesBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 08, 2022
First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation.

Kairui Yue, Simin Sun, Geng Jia

|Dec 23, 2021
Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In Vivo.

Yuqi Jiang, Jie Xu, Kairui Yue

|Mar 26, 2021
Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model.

Feng He, C James Chou, Matthias Scheiner

|Sep 14, 2020
Evolutionarily conserved sequence motif analysis guides development of chemically defined hydrogels for therapeutic vascularization.

Jia Jia, Eun Je Jeon, Mei Li

|May 12, 2020
Discovery of the First Vitamin K Analogue as a Potential Treatment of Pharmacoresistant Seizures.

Xiaoyang Li, Richard A Himes, Lyndsey C Prosser

|Apr 24, 2020
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia Activity.

Xiaoyang Li, Yuqi Jiang, Yuri K Peterson

Pageof 2

Frequent Collaborators

7 joint publications

Xiaoyang Li

3 joint publications

Yingjie Zhang

2 joint publications

Soojin Lee

1 joint publications

Hong Liu